Diabetic Ketoacidosis: Emergency Resuscitation, Fluid Protocols, Insulin Infusions, and Potassium Management
Key Clinical Takeaways
- Diabetic Ketoacidosis (DKA) is a life-threatening metabolic emergency defined by hyperglycemia, ketonemia, and high anion gap metabolic acidosis.
- Initial resuscitation prioritizes aggressive volume expansion with isotonic saline (1.0 to 1.5 L/hr in the first hour) before starting insulin.
- Insulin must never be initiated if serum potassium is <3.3 mEq/L, to prevent fatal cardiac arrhythmias from intracellular potassium shifts.
- Continuous regular insulin infusion (0.1 units/kg/hr) is titrated to close the anion gap rather than simply normalizing blood glucose.
- Dextrose (D5W) must be added to intravenous fluids when blood glucose drops below 200 mg/dL to prevent hypoglycemia while ketoacidosis resolves.
Emergency Clinical Warning
DKA is a critical hospital inpatient emergency. Fruity breath odor, rapid deep breathing (Kussmaul respiration), vomiting, and confusion require immediate 911 activation.
Pathophysiologic Triad: Hyperglycemia, Ketosis, and Acidosis
Diabetic Ketoacidosis (DKA) is an acute, life-threatening metabolic complication occurring primarily in patients with Type 1 Diabetes, but increasingly recognized in Type 2 Diabetes under severe physiologic stress or during SGLT2 inhibitor therapy. The pathogenesis is driven by absolute or relative insulin deficiency coupled with elevated counter-regulatory hormones (glucagon, catecholamines, cortisol, and growth hormone).
Without insulin to facilitate cellular glucose uptake, peripheral tissues starve, triggering unrestrained hepatic gluconeogenesis and glycogenolysis. Simultaneously, unregulated lipolysis hydrolyzes triglycerides into free fatty acids (FFAs). In the liver, FFAs are oxidized into acidic ketone bodies: acetoacetate and beta-hydroxybutyrate. Accumulation of these organic ketoacids overwhelms extracellular bicarbonate buffering, resulting in high anion gap metabolic acidosis. Massive osmotic diuresis induced by glucosuria leads to profound dehydration (typically a 5-to-7 liter fluid deficit in adults) and total-body electrolyte depletion.
Diagnostic Criteria and Laboratory Stratification
Prompt laboratory confirmation is essential. The diagnostic triad consists of: 1. Blood Glucose: Typically >250 mg/dL (13.9 mmol/L) (except in euglycemic DKA where glucose may be <200 mg/dL). 2. Arterial or Venous Blood Gas: Arterial pH <7.30 or venous pH <7.25 with serum bicarbonate <18 mEq/L. 3. Ketonemia / Ketonuria: Elevated serum beta-hydroxybutyrate (≥3.0 mmol/L) or positive urine ketones. 4. Elevated Anion Gap: Calculated as [Na+] - ([Cl-] + [HCO3-]), with values exceeding 12 mEq/L.
DKA is clinically categorized into Mild (pH 7.25-7.30, HCO3 15-18), Moderate (pH 7.00-7.24, HCO3 10-14), and Severe (pH <7.00, HCO3 <10, lethargy or coma). Anion gap tracking provides the definitive index of ketoacid clearance, far superior to urine acetoacetate dipsticks which can remain misleadingly positive for days after clinical resolution.
Emergency Fluid Resuscitation and Electrolyte Protocols
The cornerstone of DKA management in the emergency department follows a rigid, step-wise physiologic priority:
1. Fluid Resuscitation: Restoring intravascular volume is the primary imperative. In the first hour, 1,000 to 1,500 mL (15-20 mL/kg) of isotonic crystalloid (0.9% Normal Saline or Plasmalyte/Lactated Ringer's) is infused. Balanced crystalloids are increasingly favored over 0.9% saline to prevent hyperchloremic non-gap metabolic acidosis. Subsequent fluid choice depends on corrected sodium: 0.45% NaCl if corrected sodium is normal or elevated; 0.9% NaCl if corrected sodium is low. 2. Potassium Repletion: Insulin and rehydration drive potassium back into intracellular compartments. Serum potassium must be checked before starting insulin: - If K+ <3.3 mEq/L: Hold insulin! Administer IV potassium (20-40 mEq/hr) until K+ >3.3 mEq/L to prevent fatal cardiac arrest. - If K+ 3.3 - 5.2 mEq/L: Initiate insulin and add 20-30 mEq potassium per liter of IV fluids to maintain serum levels between 4.0 and 5.0 mEq/L. - If K+ >5.2 mEq/L: Start insulin, withhold potassium, and recheck every 2 hours.
Insulin Infusion Protocols and Criteria for Resolution
Once intravascular volume is expanding and potassium is verified ≥3.3 mEq/L, continuous regular insulin infusion is started at 0.1 units/kg/hr. The therapeutic target is a steady decrease in blood glucose of 50 to 75 mg/dL per hour. If glucose fails to decline by at least 50 mg/dL in the first hour, the insulin infusion rate is doubled.
Crucially, when blood glucose reaches 200 to 250 mg/dL, 5% or 10% Dextrose must be added to the intravenous fluids (e.g., D5W 0.45% NaCl) while maintaining the insulin infusion. This prevents premature hypoglycemia and cerebral edema while continuing the insulin necessary to suppress lipolysis and close the metabolic anion gap. Criteria for DKA resolution include: Blood glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, venous pH >7.30, and a normalized anion gap (≤12 mEq/L). Subcutaneous basal insulin must be injected 2 to 4 hours before discontinuing the IV insulin drip to prevent rebound ketoacidosis.
Diagnostic Stratification of Diabetic Ketoacidosis (DKA)
| Clinical Parameter | Mild DKA | Moderate DKA | Severe DKA |
|---|---|---|---|
| Plasma Glucose | >250 mg/dL | >250 mg/dL | >250 mg/dL (or euglycemic) |
| Arterial pH | 7.25 to 7.30 | 7.00 to 7.24 | < 7.00 |
| Serum Bicarbonate | 15 to 18 mEq/L | 10 to 14 mEq/L | < 10 mEq/L |
| Serum Ketones | Positive (elevated) | Positive (elevated) | Positive (strongly elevated) |
| Anion Gap | > 10 mEq/L | > 12 mEq/L | > 12 mEq/L |
| Mental Status | Alert | Alert or drowsy | Stupor or coma (ICU admission required) |
Frequently Asked Clinical Questions
Peer-Reviewed Clinical References & Guidelines
- Dhatariya KK, Glaser NS, Codner E, et al. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40.
- Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am. 2017;101(3):587-606.
- Self WH, Evans CS, Jenkins CA, et al. Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic Ketoacidosis: A Subgroup Analysis of the SMART and SALT-ED Trials. JAMA Netw Open. 2020;3(11):e2024596.